↓ Skip to main content

Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vsobservation with predefined second-line treatment after cisplatin–gemcitabine induction chemotherapy for advanced NSCLC…

Overview of attention for article published in BMC Cancer, December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
reddit
1 Redditor

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
79 Mendeley